PharmGKB summary: very important pharmacogene information for G6PD
- PMID: 22237549
- PMCID: PMC3382019
- DOI: 10.1097/FPC.0b013e32834eb313
PharmGKB summary: very important pharmacogene information for G6PD
Conflict of interest statement
R.B.A. serves as a founder and consultant for Personalis and a consultant to 23andMe. There are no conflicts of interest.
References
-
- Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267–278. - PubMed
-
- Jeffery J, Barros-Soderling J, Murray L, Wood I, Hansen R, Szepesi B, Jornvall H. Glucose-6-phosphate dehydrogenase: characteristics revealed by the rat liver enzyme structure. Eur J Biochem. 1989;186:551–556. - PubMed
-
- Kletzien RF, Harris PK, Foellmi LA. Glucose-6-phosphate dehydrogenase: a “housekeeping” enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J. 1994;8:174–181. - PubMed
-
- Pai GS, Sprenkle JA, Do TT, Mareni CE, Migeon BR. Localization of loci for hypoxanthine phosphoribosyltransferase and glucose-6-phosphate dehydrogenase and biochemical evidence of nonrandom X chromosome expression from studies of a human X-autosome translocation. Proc Natl Acad Sci USA. 1980;77:2810–2813. - PMC - PubMed
-
- Beutler E, Gelbart T, Kuhl W. Human red cell glucose-6-phosphate dehydrogenase: all active enzyme has sequence predicted by the X chromosome-encoded cDNA. Cell. 1990;62:7–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous